Incretin-based drugs fall into two main categories: DPP-4 inhibitors (like sitagliptin and linagliptin), which block the enzyme that degrades incretin hormones to boost insulin and reduce glucagon levels, and GLP-1 analogues (such as liraglutide and dulaglutide), which mimic natural GLP-1 to enhance insulin release, slow digestion, and promote satiety
Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study
Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use
PSF CARNITINE plus are ideal for weight lifters, bodybuilders, and serious athletes
